P2X7 gene polymorphisms do not appear to be a susceptibility gene locus in sporadic cases of systemic lupus erythematosus

Tissue Antigens

Volumn 72, Issue 5, 2008, Pages 487-490

  Forchap, S L ^a   Anandacoomarasamy, A ^b   Wicks, J ^c   Di Virgilio, F ^d   Baricordi, O R ^d   Rubbini, M ^d   Trotta, F ^d   Wiley, J ^a,e   Manolios, N ^b,e  

^a NEPEAN HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF FERRARA   (Italy)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Autoimmune disease; Lupus; P2X7; Polymorphisms

Indexed keywords

PURINERGIC P2X7 RECEPTOR; PURINERGIC P2 RECEPTOR;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; GENE AMPLIFICATION; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; GENETIC PREDISPOSITION; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PURINERGIC P2;

EID: 54049108853     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01136.x     Document Type: Article

References (32)

1. Tsao BP. Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 2004 : 16 : 513 21.
2. Straus SE, Sneller M, Lenardo MJ, Puck JM, Strober W. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med 1999 : 130 : 591 601.
3. Klinman DM, Steinberg AD. Inquiry into murine and human lupus. Immunol Rev 1995 : 144 : 157 93.
4. Mohan C, Datta SK. Lupus: key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 1995 : 77 : 209 20.
5. 7 receptor. J Biol Chem 2001 : 276 : 11135 42.
6. Khakh BS. Molecular physiology of P2X receptor and ATP signalling at synapses. Nat Rev Neurosci 2001 : 2 : 65 174.
7. Di Virgilio F, Chiozzi P, Ferrari D et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001 : 97 : 587 600.
8. Nath SK, Quintero-Del-Rio AI, Kilpatrick J, Feo L, Ballesteros M, Harley JB. Linkage at 12q24 with systemic lupus erythematosus (SLE) is established and confirmed in Hispanic and European American families. Am J Hum Genet 2004 : 74 : 73 82.
9. 7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J Biol Chem 1999 : 274 : 13205 10.
10. Chiozzi P, Murgia M, Falzoni S, Ferrari D, Di Virgilio F. Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures. Biochem Biophys Res Commun 1996 : 218 : 176 81.
11. Le Feuvre RA, Brough D, Iwakura Y, Takeda K, Rothwell NJ. Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production. J Biol Chem 2002 : 277 : 3210 8.
12. 7 receptor-dependent apoptosis of dendritic cells. Am J Physiol 1999 : 276 : C1139 47.
13. Laliberte R, Perregaux D, Svensson L, Pazoles CJ, Gabel CA. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages. J Immunol 1994 : 153 : 2168 79.
14. Falzoni S, Munerati M, Ferrari D, Spisani S, Moretti S, Di Virgilio F. The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 1995 : 95 : 1207 16.
15. Molloy A, Meyn PA, Smith KD, Kaplan G. Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes. J Exp Med 1993 : 177 : 1691 8.
16. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 2001 : 15 : 825 35.
17. Gu B, Bendall LJ, Wiley JS. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 1998 : 92 : 946 51.
18. Sfikakis PP, Charalambopoulos D, Vaiopoulos G, Mavrikakis M. Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases. Clin Rheumatol 1999 : 18 : 28 32.
19. Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 2003 : 48 : 2888 97.
20. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994 : 152 : 3685 92.
21. 7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 2002 : 359 : 1114 9.
22. Dao-Ung LP, Fuller SJ, Sluyter R et al. Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia. Br J Haematol 2004 : 125 : 815 7.
23. Adinolfi E, Melchiorri L, Falzoni S Chiozzi P et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 2002 : 99 : 706 8.
24. 7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet 2002 : 360 : 1935 9.
25. 7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12. Leukemia 2003 : 17 : 2097 100.
26. Starczynski J, Pepper C, Pratt G et al. The P2X7 receptor gene polymorphism 1513 A->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia. Br J Haematol 2003 : 123 : 66 71.
27. 7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome. Eur J Haematol 2004 : 72 : 259 63.
28. Cabrini G, Falzoni S, Forchap SL et al. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol 2005 : 175 : 82 9.
29. 7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 2002 : 168 : 6436 45.
30. 7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol 1999 : 163 : 1958 65.
31. Wiley JS, Dao-Ung LP, Li C et al. An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. J Biol Chem 2003 : 278 : 17108 13.
32. 7 receptor. J Biol Chem 2004 : 279 : 31287 95.